NCT00571337View on ClinicalTrials.gov

Stop Infliximab in Patients With Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Crohn Disease
Interventions
DRUG

Infliximab

Stopping infliximab in patients having been treated with this drug for at least one year and in stable remission for at least 6 month.

Trial Locations (23)

4000

CHU LIEGE - Sart Tilman, Liège

9000

Gent University Hospital, Ghent

13915

Chu Marseille - Hopital Nord, Marseille

14033

CHU CAEN, Caen

25030

Chu Besancon, Besançon

31403

Chu Toulouse, Toulouse

33075

Hopital Saint Andre, Bordeaux

33604

Hopital Haut Leveque, Pessac

34295

Chu Montpellier, Montpellier

37044

Chu Tours, Tours

44093

Chu Nantes, Nantes

67091

Chu Strasbourg, Strasbourg

69495

CHU LYON, Pierre-Bénite

75010

Hopital Lariboisiere, Paris

Hopital Saint Louis, Paris

75015

Hopital Georges Pompidou, Paris

76031

Chu Rouen, Rouen

80054

Chu Amiens, Amiens

92110

Hopital Beaujon, Clichy

92700

Hopital Louis Mourier, Colombes

93370

Ch Le Raincy Montfermeil, Montfermeil

94010

Hopital Henri Mondor, Créteil

Unknown

CHRU Lille, Lille

All Listed Sponsors
lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER

NCT00571337 - Stop Infliximab in Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter